Article
Circulating inflammatory cytokines in relation to the risk of renal cell carcinoma: A gender-specific two-sample Mendelian randomization study.
Cancer medicine - 1 Nov 2023
Tao Shuixiang, Lin Yiwei, Huang Shengqiang, Lin Shen, Jin Ke, Chen Hong
Abstract excerpt
BACKGROUND: Currently there is no specific molecular biomarker for the diagnosis and treatment of renal cell carcinoma (RCC). Here we performed a gender-specific two-sample Mendelian randomization analysis to systematically assess the effects of circulating cytokines on RCC. METHODS: We have employed cis-quantitative trait loci as instrumental variables for the protein levels and expression of circulating...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
